#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage I Iron overload Gastrointestinal disorder Muscular dystrophy Bulbospinal muscular atrophy congenital Systemic mastocytosis Frostbite Myotonia Cystic fibrosis Dent's disease Systemic sclerosis pulmonary Infertility male Cardiac sarcoidosis Sarcoidosis Anti-neutrophil cytoplasmic antibody positive vasculitis More trials…

    Learn about Rare Diseases

    Hereditary ataxia – Life with Disease Pemphigus – Life with Disease Immunodeficiency congenital – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Burkitt’s lymphoma – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Langerhans cell sarcoma – Diagnostics Ehlers-Danlos syndrome – Life with Disease Lysosomal storage disorder – Diagnostics Mucous membrane pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecubectedin Zofenopril Calcium Mva-209-Fsp-B4 Censavudine Iloprost Trometamol POTASSIUM CLAVULANATE Dapirolizumab Pegol Juniper Berry Oil Bp1.7881A Metoclopramide Bms-986449-03 Cipepofol Medi0618 ULIXERTINIB HSP-CAR30 Human Coagulation Factor Ix Flutemetamol (18F) BI-1607 Elexacaftor Cortisone More therapies…

    Learn about Your Condition

    Desmoplastic melanoma Type IIa hyperlipidaemia Inguinal hernia Androgenetic alopecia Colon cancer Neurodevelopmental disorder Erythema multiforme Polycystic ovarian syndrome Adrenocortical carcinoma Encephalitis autoimmune VEXAS syndrome Netherton's syndrome Hypotension Retroperitoneal fibrosis Constipation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic inflammatory demyelinating polyradiculoneuropathy

  • A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Empasiprubart
    • Human Normal Immunoglobulin (Iv)
    Austria Bulgaria Czechia Denmark Estonia France +13

  • A study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Empasiprubart
    Austria Bulgaria Czechia Denmark Estonia Finland +9

  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • IMEROPRUBART
    Austria Belgium Bulgaria Denmark Estonia Finland +13

  • Study of DNTH103 Treatment for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: Comparing Effectiveness with Placebo

    Recruiting

    3 1
    Investigated Drugs:
    • Dnth103
    Belgium Bulgaria Croatia Denmark France Germany +6

  • Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece Italy Poland +2

  • Study on Long-term Safety and Efficacy of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    Belgium Bulgaria Czechia Denmark France Germany +8
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!